Primary cutaneous lymphomas: A population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003

References

• Groves F D, Linet M S, Travis L B, Devesa S S. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240–1251
   PubMed Web of Science ®Google Scholar
• Willemze R, Jaffe E S, Burg G, Cerroni L, Berti E, Swerdlow S H, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–3785
   PubMed Web of Science ®Google Scholar
• Savage K J, Chhanabhai M, Gascoyne R D, Connors J M. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004; 15: 1467–1475
   PubMed Web of Science ®Google Scholar
• Wejroch M P, Cornillet P, Perceau G, Durlach A, Bernard P. Frequency of associated malignancies in cutaneous lymphomas: a retrospective study of 86 cases. Ann Dermatol Venereol 2004; 131: 339–345
   PubMed Web of Science ®Google Scholar
• Yasukawa K, Kato N, Kodama K, Hamasaka A, Hata H. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification. J Cutan Pathol 2006; 33: 487–491
   PubMed Web of Science ®Google Scholar
• Bouaziz J D, Bastuji-Garin S, Poszepczynska-Guigne E, Wechsler J, Bagot M. Relative frequency and survival of patients with primary cutaneous lymphomas: data from a single-centre study of 203 patients. Br J Dermatol 2006; 154: 1206–1207
   PubMed Web of Science ®Google Scholar
• Weinstock M A, Horm J W. Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA 1988; 260: 42–46
   PubMed Web of Science ®Google Scholar
• Weinstock M A, Gardstein B. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 1999; 89: 1240–1244
   PubMed Web of Science ®Google Scholar
• Dores G, William F, Devesa S. Cutaneous lymphomas reported to the National Cancer Institute's Surveillance Epidemiology, and End Results Program: applying the New WHO-European Organisation for Research and Treatment of Cancer Classification System. J Clin Oncol 2005; 23: 7246–7248
   PubMed Web of Science ®Google Scholar
• Criscione V D, Weinstock M A. Incidence of cutaneous T-cell lymphoma in the United States, 1973–2002. Arch Dermatol 2007; 143: 854–859
   PubMed Web of Science ®Google Scholar
• Fritz A, Percy C, Jack A, Shanmugaratna K, Sobin L, Parkin D M, et al. International Classification of Diseases for Oncology3rd edn. World Health Organisation, Geneva 2001
   Google Scholar
• Kim Y H, Willemze R, Pimpinelli N, Whittaker S, Olsen E A, Ranki A, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 479–484
   PubMed Web of Science ®Google Scholar
• Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713–1722
   PubMed Web of Science ®Google Scholar
• Waterhouse J, Muir C, Correa P, Powell J. Cancer incidence in five continents, editors. IARC scientific publication. International Agency for Research on Cancer, LyonFrance 1976; 3: 15
   Google Scholar
• Oehlert G W. A note on the delta method. Am Stat 1992; 46: 27–29
   Web of Science ®Google Scholar
• Salhany K E, Cousar J B, Greer J P, Casey T T, Fields J P, Collins R D. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol 1988; 132: 265–277
   PubMed Web of Science ®Google Scholar
• Smith B D, Smith G L, Cooper D L, Wilson L D. The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry. J Clin Oncol 2005; 23: 3390–3395
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, et al. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 2006; 24: 1376–1382
   PubMed Web of Science ®Google Scholar
• Alexander D D, Mink P J, Adami H O, Chang E T, Cole P, Mandel J S, Trichopoulos D. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007; 120(Suppl 12)1–39
   PubMed Web of Science ®Google Scholar
• Senff N J, Hoefnagel J J, Jansen P M, Vermeer M H, van Baarlen J, Blokx W A, et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007; 25: 1581–1587
   PubMed Web of Science ®Google Scholar
• Higginbotham J C, Moulder J, Currier M. Rural v. urban aspects of cancer: first-year data from the Mississippi Central Cancer Registry. Fam Commun Health 2001; 24: 1–9
   PubMed Web of Science ®Google Scholar
• Morales Suárez-Varela M M, Olsen J, Kaerlev L, Guénel P, Arveux P, Wingren G, et al. Are alcohol intake and smoking associated with mycosis fungoides? A European multicentre case–control study. Eur J Cancer 2001; 37: 392–397
   PubMed Web of Science ®Google Scholar
• Fischmann A B, Bunn P A, Jr, Guccion J G, Matthews M J, Minna J D. Exposure to chemicals, physical agent, and biologic agents in mycosis fungoides and Sezary syndrome. Cancer Treat Rep 1979; 63: 591–596
   PubMedGoogle Scholar
• Morales-Suárez-Varela M M, Olsen J, Johansen P, Kaerlev L, Guénel P, Arveux P, et al. Occupational sun exposure and mycosis fungoides: a European multicentre case–control study. J Occup Environ Med 2006; 46: 390–393
   Web of Science ®Google Scholar
• Koh H K, Charif M, Weinstock M A. Epidemiology and clinical manifestations of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995; 9: 943–960
   PubMed Web of Science ®Google Scholar
• van Doorn R, Van Haselen C W, van Voorst Vader P C, Geerts M L, Heule F, de Rie M, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol 2000; 136: 504–510
   PubMed Web of Science ®Google Scholar
• Keehn C A, Belongie I P, Shistik G, Fenske N A, Glass L F. The diagnosis, staging, and treatment options for mycosis fungoides. Cancer Control 2007; 14: 102–111
   PubMedGoogle Scholar
• Morales Suarez-Varela M M, Llopis Gonzales A, Marquina Vila A, Bell J. Mycosis fungoides: review of epidemiological observations. Dermatology 2000; 201: 21–28
   PubMed Web of Science ®Google Scholar
• Kim Y, Howard L, Mraz-Gernhard S, Varghese A, Hoppe R T. Long-term outcome of 525 patients with Mycosis Fungoides and Sézary syndrome. Arch Dermatol 2003; 139: 857–866
   PubMed Web of Science ®Google Scholar